Cannabis Science — page 5

Build a cannabis grow tent the right way: tent sizing, LED PPFD, inline fan CFM math, carbon filters, airflow, and the assembly order that prevents waste.

Learn to read cannabis trichomes with a loupe or microscope. Decode clear, cloudy, and amber to time your harvest for the exact high you want.

Phytol and sabinene are minor cannabis terpenes with intriguing preclinical research on calm, inflammation, and the entourage effect. The honest science.

Most aromatic terpenes burn off before you inhale them. Here is the science on how little actually reaches your bloodstream and brain.

THCA flower and delta-9 flower come from the same plant. Heat converts THCA into delta-9 THC, so smoked, they feel identical. Here's the real difference.

Triploid cannabis carries three chromosome sets instead of two, making it nearly seedless. Here's how it's bred and what the science actually shows.

Master VPD (vapour pressure deficit) for cannabis. Learn target ranges by stage, leaf-temp offset, how to read a VPD chart, and dial in your climate.

Does bong water really filter cannabis smoke? The science is messier than you think. Here is what water removes, what it keeps, and what it costs you.

Delta-8 and delta-10 reliably trigger THC drug tests, and HHC often does too. Here is the science on why hemp cannabinoids are not test-safe.

Acetylated cannabinoids like THC-O release ketene — a documented severe lung toxin — when vaped. The 2026 chemistry paper everyone selling them ignored.

Prop 64 hit its 10-year mark. What California legalization actually changed — genetics, policy, culture — and what it didn't fix. The data and the lessons.

A 2026 study found CBC and CBG with silver nanoparticles killed MRSA 64x more effectively than silver alone — with zero resistance development. The science.

A 2026 cohort of 300,000+ patients found cannabis use disorder linked to 3.87x higher lung cancer risk. The data, the caveats, and what it means for users.

A 2026 scoping review of 28 RCTs across 12 DSM-5 conditions. Where cannabinoids show benefit, where evidence is thin, and what we still don't know.

Depressed patients widely use cannabis for sleep — and the science is nuanced. Real perceived benefit, real architecture concerns. What 2026 research shows.

A 2026 longitudinal study of 11,000+ youth shows THC exposure tracks with measurable brain trajectory changes — while CBD does not. The data parents need.

The first randomized trial of cannabis for acute migraine: vaporized THC+CBD flower beat placebo for pain freedom at 2 hours. What the science actually says.

Cannabis flavonoids — especially cannflavin A — match ibuprofen for anti-inflammatory potency. The third bioactive category most consumers have never heard of.

The UK Medical Cannabis Registry tracked 698 patients prescribed cannabis for depression. Mood, sleep, and anxiety all improved — with one important caveat.

The DEA finalized cannabis rescheduling to Schedule III in April 2026. What changed for research, taxes, and banking — and what didn't change for consumers.

Cannabis terpenes relieve pain via adenosine A2A receptors, not CB1/CB2 — with morphine-comparable analgesia. Why this rewrites the pain conversation.

A 2026 study: cannabis works better for chronic pain when it ALSO improves sleep, stress, and mood. Why multi-system effects matter — and how to use them.

A 2026 study found CBD reverses nicotine-induced glymphatic system damage in animal models. The neuroscience and the practical takeaway for vapers.

CBD has poor bioavailability — only 6-19% reaches your bloodstream. New nanoparticle research could change that, opening doors to stroke therapy.